Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13942-13949
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13942
Table 1 Patient characteristics n (%)
CharacteristicsTotal populationNegative appendicitisPathologically proven appendicitisP value
(n = 224)(n = 47)(n = 177)
Age (yr)0.052
< 1526 (11.6)10 (21.3)16 (9.0)
15-64169 (75.4)33 (70.2)136 (76.9)
≥ 6529 (13.0)4 (8.5)25 (14.1)
Gender0.092
Male88 (39.3)13 (27.7)75 (42.4)
Female136 (60.7)34 (72.3)102 (57.6)
Body mass index (kg/m2)0.635
< 2052 (27.1)12 (31.6)40 (26.0)
20-25106 (55.2)21 (55.2)85 (55.2)
> 2534 (17.7)5 (13.2)29 (18.8)
Comorbidity0.350
Charlson index = 0217 (96.9)47 (100.0)170 (96.0)
Charlson index > 07 (3.1)0 (0.0)7 (4.0)
Symptom duration before presentation0.740
< 72 h129 (58.1)26 (55.3)103 (58.9)
≥ 72 h93 (41.9)21 (44.7)72 (41.1)
Body temperature (°C)0.755
< 37.8119 (88.8)28 (87.5)91 (89.2)
≥ 37.815 (11.2)4 (12.5)11 (10.8)
Presenting symptom0.507
Abdominal pain219 (97.8)47 (100.0)172 (97.2)
Indigestion1 (0.4)0 (0.0)1 (0.6)
Fever/chill4 (1.8)0 (0.0)4 (2.2)
Pain migration0.507
No114 (53.3)26 (57.8)88 (52.1)
Yes100 (46.7)19 (42.2)81 (47.9)
Degree of tenderness0.383
Mild4 (1.8)0 (0.0)4 (2.3)
Moderate217 (96.9)47 (100.0)170 (96.0)
Severe3 (1.3)0 (0.0)3 (1.7)
RLQ localization of pain0.559
Discrete205 (91.5)42 (89.4)163 (92.1)
Obscure19 (8.5)5 (10.6)14 (7.9)
Lab findings, median (range)
WBC count (× 103/mm3)9.55 (4.0-29.1)9.3 (4.6-25.9)9.6 (4.0-29.1)0.833
Platelet count (× 103/mm3)250 (157- 564)277 (202-564)241 (157-341)0.005
Creatinine (mg/dL)0.64 (0.41- 1.11)0.56 (0.41-0.69)0.70 (0.46-1.11)0.036
Albumin (g/dL)4.30 (3.3-5.4)4.40 (3.3-5.2)4.30 (3.3-5.4)0.989
Total bilirubin (mg/dL)0.50 (0.2-1.5)0.55 (0.2-1.5)0.77 (0.2-2.2)0.020
Neutrophil fraction0.359
< 80%160 (72.4)36 (78.3)124 (70.9)
≥ 80%61 (27.6)10 (21.7)51 (29.1)
Table 2 Reevaluations of computed tomography scans preoperatively interpreted as indeterminate for appendicitis n (%)
Total populationNegative appendicitisPathologically proven appendicitisP value
(n = 224)(n = 46)(n = 178)
Appendiceal visualization1.000
No6 (2.7)1 (2.2)5 (2.8)
Yes218 (97.3)45 (97.8)173 (97.2)
Appendiceal diameter< 0.001
< 6.0 mm89 (39.7)29 (63.0)60 (33.7)
≥ 6.0 mm135 (60.3)17 (37.0)118 (66.3)
Thickness of appendiceal wall0.175
< 2.0 mm54 (24.1)15 (32.6)39 (21.9)
≥ 2.0 mm170 (75.9)31 (67.4)139 (78.1)
Appendiceal wall enhancement0.059
No138 (63.3)34 (75.6)104 (63.3)
Yes80 (36.7)11 (24.4)69 (39.9)
Presence of intraluminal air0.024
No139 (63.8)22 (48.9)117 (67.6)
Yes79 (36.2)23 (51.1)56 (32.4)
Presence of appendicolith1.000
No206 (94.5)43 (95.6)163 (94.2)
Yes12 (5.5)2 (4.4)10 (5.8)
Presence of periappendiceal fat stranding0.001
No155 (71.1)41 (91.1)114 (65.9)
Yes63 (28.9)4 (8.9)59 (34.1)
Presence of periappendiceal fluid collection0.669
No216 (96.4)44 (95.7)172 (96.6)
Yes8 (3.6)2 (4.3)6 (3.4)
Presence of periappendiceal lymphadenopathy1.000
No200 (89.3)41 (89.1)159 (89.3)
Yes24 (10.7)5 (10.9)19 (10.7)
Presence of coexisting lesions0.084
No169 (75.4)30 (65.2)139 (78.1)
Yes55 (24.6)16 (34.8)39 (21.9)
Table 3 Incidence of coexisting inflammatory lesions
Coexisting lesionsIncidence (n)% (n = 224)
Ileocolitis3717.0
Terminal ileitis104.5
Periappendiceal fluid collection41.0
Pelvic inflammatory disease20.9
Epiploic appendigitis10.4
Table 4 Risk estimations n (%)
GroupsNumber of risk factors1Patients with positive appendicitisOR95%CIP value
Low-risk group0-173 (65.8)1.000
High-risk group2-3105 (92.9)6.8323.013-15.4540.001